Gratis con tu RUT
Conecta el RUT de tu empresa
Mira tu probabilidad de ganar, qué postular y dónde ganas.
Crear cuenta gratisHOSPITAL CLINICO DE MAGALLANES DR. LAUTARO NAVARRO AVARIA·Punta Arenas, Región de Magallanes y de la Antártica
Gratis con tu RUT
Regístrate gratis y te decimos tu probabilidad de ganar este tipo de licitación, si tu empresa ya compitió por estos productos y contra quién.
| ABBVIE PRODUCTOS FARMACEUTICOS LIMITADA76.212.732-6 | FARMACIAS1.440 Comprimido·15 oferentes | $37.275 | $53.676.000 | $53.676.000 | Adjudicada |
| ABBVIE PRODUCTOS FARMACEUTICOS LIMITADA76.212.732-6 | FARMACIAS1.440 Comprimido·15 oferentes | $18.638 | $26.838.720 | $26.838.720 | Adjudicada |
| CLINICAL MARKET S.A.76.111.113-2 | FARMACIAS480 Unidad·15 oferentes | $195.000 | $93.600.000 | $93.600.000 | Adjudicada |
| NOVOFARMA SERVICE S A96.945.670-2 | FARMACIAS1.440 Comprimido·15 oferentes | $4.967 | $7.152.480 | $7.152.480 | Adjudicada |
| GADOR LIMITADA76.084.945-6 | FARMACIAS672 Comprimido·15 oferentes | $60.329 | $40.541.088 | $40.541.088 | Adjudicada |
| NOVO NORDISK FARMACEUTICA LIMITADA76.711.330-7 | FARMACIAS4.800 Unidad·15 oferentes | $89.000 | $427.200.000 | $427.200.000 | Adjudicada |
| NOVO NORDISK FARMACEUTICA LIMITADA76.711.330-7 | FARMACIAS960 Unidad·15 oferentes | $89.000 | $85.440.000 | $85.440.000 | Adjudicada |
| NOVARTIS CHILE S A83.002.400-k | FARMACIAS480 Unidad·15 oferentes | $633.261 | $303.965.280 | $303.965.280 | Adjudicada |
| NOVOFARMA SERVICE S A96.945.670-2 | VALSARTAN144.000 Comprimido·15 oferentes | $989 | $142.416.000 | $142.416.000 | Adjudicada |
| NOVOFARMA SERVICE S A96.945.670-2 | VALSARTAN28.800 Comprimido·15 oferentes | $1.090 | $31.392.000 | $31.392.000 | Adjudicada |
| NOVARTIS CHILE S A83.002.400-k | FARMACIAS58 Unidad·15 oferentes | $412.168 | $23.905.744 | $23.905.744 | Adjudicada |
| LABORATORIOS KAMPAR S A99.565.040-1 | METOTREXATO6.720 Unidad·15 oferentes | $22.200 | $149.184.000 | $149.184.000 | Adjudicada |
| NOVO NORDISK FARMACEUTICA LIMITADA76.711.330-7 | FARMACIAS288 Unidad·15 oferentes | $40.000 | $11.520.000 | $11.520.000 | Adjudicada |
| NOVARTIS CHILE S A83.002.400-k | FARMACIAS84.000 Unidad·15 oferentes | $1.256 | $105.504.000 | $105.504.000 | Adjudicada |
| JOHNSON Y JOHNSON DE CHILE S A93.745.000-1 | FARMACIAS120 Unidad·15 oferentes | $660.000 | $79.200.000 | $79.200.000 | Adjudicada |
| GLAXOSMITHKLINE CHILE FARMACEUTICA LIMITADA85.025.700-0 | FLUTICASONA2.880 Unidad·15 oferentes | $42.000 | $120.960.000 | $120.960.000 | Adjudicada |
| SANOFI-AVENTIS DE CHILE S.A.92.251.000-8 | FARMACIAS240 Unidad·15 oferentes | $429.410 | $103.058.400 | $103.058.400 | Adjudicada |
| SANOFI-AVENTIS DE CHILE S.A.92.251.000-8 | FARMACIAS96 Unidad·15 oferentes | $595.000 | $57.120.000 | $57.120.000 | Adjudicada |
| BRISTOL MYERS SQUIBB DE CHILE AGENC DE E R SQUIBB & SONS INTERAM CORPO92.363.000-7 | FARMACIAS2.880 Comprimido·15 oferentes | $22.043 | $63.483.840 | $63.483.840 | Adjudicada |
| ASTRAZENECA SA76.447.530-5 | FARMACIAS72 Unidad·15 oferentes | $1.594.758 | $114.822.576 | $114.822.576 | Adjudicada |
| NOVOFARMA SERVICE S A96.945.670-2 | ÁCIDO VALPROICO960 Frasco·15 oferentes | $14.032 | $13.470.720 | $13.470.720 | Adjudicada |
| PFIZER CHILE S.A.96.981.250-9 | FARMACIAS7.200 Comprimido·15 oferentes | $20.964 | $150.940.800 | $150.940.800 | Adjudicada |
| PFIZER CHILE S.A.96.981.250-9 | FARMACIAS2.160 Comprimido·15 oferentes | $16.071 | $34.713.360 | $34.713.360 | Adjudicada |
| NOVARTIS CHILE S A83.002.400-k | FARMACIAS1.200 Unidad·15 oferentes | $316.631 | $379.957.200 | — | Aceptada |
| MUNNICH PHARMA MEDICAL SPA80.447.400-5 | FARMACIAS84.000 Unidad·15 oferentes | $1.678 | $140.952.000 | — | Aceptada |
| 28-04-2026 |
| $3.767.903 |
| 1058012-1003-SE26 | BRISTOL MYERS SQUIBB DE CHILE AGENC DE E R SQUIBB & SONS INTERAM CORPO92.363.000-7 | 28-04-2026 | $786.935 |
| 1058012-998-SE26 | NOVARTIS CHILE S A83.002.400-k | 28-04-2026 | $1.793.568 |
| 1058012-858-SE26 | NOVOFARMA SERVICE S A96.945.670-2 | 13-04-2026 | $2.760.229 |
| 1058012-846-SE26 | SANOFI-AVENTIS DE CHILE S.A.92.251.000-8 | 13-04-2026 | $1.021.996 |
| 1058012-1093-SE26 | AstraZeneca76.447.530-5 | 11-05-2026 | $3.795.524 |
| 1058012-822-SE26 | NOVOFARMA SERVICE S A96.945.670-2 | 01-04-2026 | $3.631.880 |
| 1058012-1088-SE26 | SANOFI-AVENTIS DE CHILE S.A.92.251.000-8 | 07-05-2026 | $1.021.996 |
| 1058012-676-SE26 | NOVARTIS CHILE S A83.002.400-k | 24-03-2026 | $7.488.146 |
| 1058012-651-SE26 | ABBVIE PRODUCTOS FARMACEUTICOS LIMITADA76.212.732-6 | 23-03-2026 | $3.326.883 |
| 1058012-649-SE26 | CLINICAL MARKET S.A.76.111.113-2 | 23-03-2026 | $3.712.800 |
| 1058012-648-SE26 | NOVARTIS CHILE S A83.002.400-k | 23-03-2026 | $15.071.612 |
| 1058012-647-SE26 | JOHNSON Y JOHNSON DE CHILE S A93.745.000-1 | 23-03-2026 | $2.356.200 |
| 1058012-645-SE26 | AstraZeneca76.447.530-5 | 23-03-2026 | $3.795.524 |
| 1058012-639-SE26 | Novo Nordisk Farmaceutica Limitada76.711.330-7 | 23-03-2026 | $10.591.000 |
| 1058012-593-SE26 | NOVARTIS CHILE S A83.002.400-k | 11-03-2026 | $4.483.920 |
| 1058012-556-SE26 | SANOFI-AVENTIS DE CHILE S.A.92.251.000-8 | 09-03-2026 | $1.021.996 |
| 1058012-529-SE26 | ABBVIE PRODUCTOS FARMACEUTICOS LIMITADA76.212.732-6 | 05-03-2026 | $1.330.718 |
| 1058012-528-SE26 | JOHNSON Y JOHNSON DE CHILE S A93.745.000-1 | 05-03-2026 | $3.927.000 |
| 1058012-527-SE26 | BRISTOL MYERS SQUIBB DE CHILE AGENC DE E R SQUIBB & SONS INTERAM CORPO92.363.000-7 | 05-03-2026 | $1.573.870 |
| 1058012-515-SE26 | Novo Nordisk Farmaceutica Limitada76.711.330-7 | 04-03-2026 | $21.182.000 |
| 1058012-514-SE26 | Novo Nordisk Farmaceutica Limitada76.711.330-7 | 04-03-2026 | $2.118.200 |
| 1058012-485-SE26 | NOVARTIS CHILE S A83.002.400-k | 26-02-2026 | $11.303.709 |
| 1058012-359-SE26 | JOHNSON Y JOHNSON DE CHILE S A93.745.000-1 | 17-02-2026 | $4.712.400 |
| 1058012-322-SE26 | ABBVIE PRODUCTOS FARMACEUTICOS LIMITADA76.212.732-6 | 16-02-2026 | $3.326.883 |
| 1058012-321-SE26 | ABBVIE PRODUCTOS FARMACEUTICOS LIMITADA76.212.732-6 | 16-02-2026 | $1.330.718 |
| 1058012-320-SE26 | CLINICAL MARKET S.A.76.111.113-2 | 16-02-2026 | $3.712.800 |
| 1058012-319-SE26 | AstraZeneca76.447.530-5 | 16-02-2026 | $1.897.762 |
| 1058012-270-SE26 | NOVARTIS CHILE S A83.002.400-k | 13-02-2026 | $4.483.920 |
| 1058012-222-SE26 | Novo Nordisk Farmaceutica Limitada76.711.330-7 | 05-02-2026 | $8.472.800 |
| 1058012-90-SE26 | ABBVIE PRODUCTOS FARMACEUTICOS LIMITADA76.212.732-6 | 20-01-2026 | $6.653.766 |
| 1058012-89-SE26 | ABBVIE PRODUCTOS FARMACEUTICOS LIMITADA76.212.732-6 | 20-01-2026 | $1.152.218 |
| 1058012-86-SE26 | CLINICAL MARKET S.A.76.111.113-2 | 20-01-2026 | $3.712.800 |
| 1058012-83-SE26 | BRISTOL MYERS SQUIBB DE CHILE AGENC DE E R SQUIBB & SONS INTERAM CORPO92.363.000-7 | 20-01-2026 | $786.935 |
| 1058012-81-SE26 | PFIZER CHILE S.A.96.981.250-9 | 20-01-2026 | $1.070.971 |
| 1058012-59-SE26 | NOVARTIS CHILE S A83.002.400-k | 15-01-2026 | $4.483.920 |
| 1058012-45-SE26 | Novo Nordisk Farmaceutica Limitada76.711.330-7 | 12-01-2026 | $21.182.000 |
| 1058012-34-SE26 | SANOFI-AVENTIS DE CHILE S.A.92.251.000-8 | 13-01-2026 | $1.021.996 |